SCHEMBL29512759

SCHEMBL29512759

COCC1CCCCN1c1c(Cl)cccc1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
GAA P10253 2/20 0.46
ALDH1A1 P00352 8/20 0.45
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.45
LMNA P02545 3/20 0.42
MCOLN3 Q8TDD5 1/20 0.42
HTT P42858 2/20 0.38
RECQL P46063 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CHRNB4 P30926 1/20 0.38
CHRNA3 P32297 1/20 0.38
MAPT P10636 3/20 0.37
HPGD P15428 1/20 0.37
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
KCNH2 Q12809 1/20 0.37
CUL4A Q13619 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29512678 0.89 CYP1A2 (0.45) CYP1A2CYP2C9CYP2C19GAAALDH1A1
SCHEMBL29512722 0.88 ALDH1A1 (0.50) CYP1A2CYP2C9CYP2C19GAAALDH1A1
SCHEMBL29512788 0.85 CUL4A (0.51) CYP1A2CYP2C9CYP2C19GAAALDH1A1
SCHEMBL29512729 0.83 ALDH1A1 (0.46) CYP1A2CYP2C9CYP2C19GAAALDH1A1
SCHEMBL29512782 0.82 ALDH1A1 (0.45) CYP1A2CYP2C9CYP2C19GAAALDH1A1
SCHEMBL29512596 0.81 CYP1A2 (0.44) CYP1A2CYP2C9CYP2C19GAAALDH1A1
SCHEMBL29512590 0.81 ALDH1A1 (0.50) CYP1A2CYP2C9CYP2C19GAAALDH1A1
SCHEMBL29512714 0.80 DRD2 (0.40) DRD2DRD3KCNH2
SCHEMBL9899670 0.72 MAPT (0.54) CYP1A2CYP2C9CYP2C19ALDH1A1KMT2A
SCHEMBL9899672 0.72 MAPT (0.54) CYP1A2CYP2C9CYP2C19ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076383-A1 SULFONANILIDE AND BENZYLSULFONYL DERIVATIVES, AND COMPOSITIONS AND METHODS THEREOF Lysoway Therapeutics, Inc. (US) 2022-04-14 WO disclosed